Overview
Hereditary thrombocytopenic disorders encompass a range of genetic conditions characterized by impaired platelet production or function, leading to thrombocytopenia and increased bleeding risk 1.Diagnosis
Genetic testing for specific mutations (e.g., WAS, ITGA2B, THPO) 1.
Complete blood count (CBC) showing low platelet count 1.
Bone marrow examination to assess megakaryocyte morphology and function 1.
Peripheral blood smear to evaluate platelet morphology 1.Management
First-line treatments: Corticosteroids for immune-mediated thrombocytopenia 1.
Second-line treatments: Immune globulin intravenous (IVIG) for short-term control 1.
Platelet transfusions: For acute bleeding episodes 1.
Splenectomy: Considered in severe cases unresponsive to medical therapy 1.Special Populations
Pregnancy: Close monitoring required; management strategies may include IVIG and corticosteroids 1.
Pediatrics: Early diagnosis crucial; tailored treatment plans considering growth and development 1.
Elderly: Increased risk of bleeding; cautious approach to invasive procedures and medication side effects 1.
Comorbidities: Tailor treatment to manage coexisting conditions while addressing thrombocytopenia 1.Key Recommendations
Utilize genetic testing for definitive diagnosis and family screening 1 (Evidence: Strong).
Initiate corticosteroid therapy as first-line management for immune-mediated forms 1 (Evidence: Strong).
Consider splenectomy in patients with severe, refractory thrombocytopenia after exhausting medical options 1 (Evidence: Moderate).References
1 Poncz M, Iannone R, Werner EM. Hematology grants workshop. Hematology. American Society of Hematology. Education Program 2003. link